GlassScriptPhysician profile
Lane C Robeson
NPI 1891762282
$2,649.44
in general payments reported to CMS, 2019-2025
10 companies · $1,854 in 2025
The $1,854 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2021: $87.28 · 2022: $65.53 · 2023: $60.17 · 2024: $277 · 2025: $1,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $642 · Entertainment: $49.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $641.88 |
| Entertainment | $49.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,692.96 | 2021-2025 | Clariti Contact Lens, Misight Contact Lens |
| Maculogix, INC. | $239.34 | 2019 | |
| Integra Lifesciences Corporation | $161.92 | 2022-2025 | Biofix, Biodfactor, Biodoptix |
| Alcon Vision LLC | $160.40 | 2021-2025 | Precision 1 |
| Lkc Technologies, INC. | $116.87 | 2023-2025 | |
| Visionix USA, INC | $91.75 | 2024 | Optical Coherence Tomography Hoct-1f |
| Glaukos Corporation | $75.07 | 2019-2025 | Idosetr |
| Optos, INC. | $49.14 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $31.34 | 2019 | |
| Allergan, INC. | $30.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lane Robeson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.